Potential role of neuropeptide ligands in the treatment of overeating

CNS Drugs

Volumn 7, Issue 6, 1997, Pages 419-426

  Rowland, Neil E ^a,c   Kalra, Satya P ^b  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; BOMBESIN; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; GALANIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; INTERMEDIN; NEUROPEPTIDE; NEUROPEPTIDE Y; OXYTOCIN;

AMYGDALOID NUCLEUS; ANTERIOR HYPOTHALAMUS; APPETITE; BODY WEIGHT; FEEDING DISORDER; FOOD INTAKE; HUMAN; LIGAND BINDING; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; REVIEW;

EID: 0030825473     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199707060-00001     Document Type: Review

References (77)

1. Rowland NE, Morien A, Li BH. Review: The physiology and brain mechanisms of feeding. Nutrition 1996; 12: 626-39
2. Bray GA. Evaluation of drugs for treating obesity. Obes Res 1995; 3 Suppl. 4: 425S-34S
3. Elks ML. Appetite suppressants as adjuncts in the treatment of obesity. J Fam Prac 1996; 42: 287-92
4. Goldstein DJ, Potvin JH. Long-term weight loss: The effect of pharmacologic agents. Am J Clin Nutr 1994; 60: 647-57
5. Stunkard AJ. Current views on obesity. Am J Med 1996; 100: 230-5
6. Clark JT, Kalra PS, Crowley WR, et al. Neuropeptide Y and pancreatic polypeptide stimulates feeding behavior in rats. Endocrinology 1984; 115: 427-9
7. Clark JT, Kalra PS, Crowley WR, et al. Neuropeptide Y stimulates feeding, hut inhibits sexual behavior in rats. Endocrinology 1985; 117: 2435-42
8. Kalra SP, Kalra PS. Is neuropeptide Y (NPY) a naturally-occurring appetite transducer? Curr Opin Endocrinol Diabetes 1996; 3: 157-63
9. Kalra SP, Dube MG, Sahu A, et al. Neuropeplide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991; 88: 10931-5
10. White JD, Kershaw M. Increased hypothalamic neuropeptide Y expression following food deprivation. Mol Cell Neurosci 1990; 1: 41-8
11. Dube MG, Xu B, Crowley WR, et al. Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 1994; 646: 341-4
12. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by loss of neuropeptide Y. Science 1996; 274: 1704-7
13. Kalra SP, Dube MG, Fournier A, et al. Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol Behav 1991; 50: 5-9
14. Stanley BG, Magdalin W, Seirafi A, et al. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides 1992; 13: 581-7
15. Weinberg DH, Sirinathsighhji DT, Tan CP, et al. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 1996; 271: 16435-8
16. Gerald C, Walker MW, Criscione L, et al. A receptor subtype involved in neuropeptide Y-induced food intake. Nature 1996; 372: 168-71
17. Hu Y, Bloomquist BT, Cornfield LJ, et al. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 1996; 271: 26315-9
18. O'Shea D, Morgan DGA, Meeran K, et al. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 1997; 138: 196-202
19. 32]-neuropeptide Y (NPY): a competitive antagonist of NPY in the rai hypothalamus. J Med Chem 1994; 37: 811-5
20. Leibowitz SF, Xuereb M, Kim T. Blockade of natural and neuropeptide Y-induced carbohydrate feeding by a receptor antagonist PYX-2. Neuroreport 1992; 3: 1023-6
21. 32]-NPY (27-36) infused into the hypothalamus of the rat. Brain Res Bull 1995; 37: 237-45
22. Beck B, Stricker-Krongrad A, Musse N, et al. Putative neuropeptide Y antagonist failed to decrease overeating in obese Zucker rats. Neurosci Lett 1994; 181: 126-8
23. Daniels AJ, Matthews JE, Slepetis RJ, et al. High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 1995; 92: 9067-71
24. 1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. Endocrinology 1996; 137: 3177-82
25. 1 receptor antagonist, BIBP3226. Eur J Pharmacol 1994; 271: R11-3
26. 1 receptor antagonist. FEBS Lett 1995; 362: 192-6
27. Leibowitz SF. Brain peptides and obesity: pharmacologic treatment. Ohes Res 1995; 3 Suppl. 4: 573S-89S
28. Lin L, York DA, Bray GA. Comparison of Osborne-Mendel and S5B/PL strains of rat: central effects of galanin, NPY, B-casomorphin and CRH on intake of high-fat and low-fat diets. Obes Res 1996; 4: 117-24
29. Smith BK, York DA, Bray GA. Effects of dietary preference and galanin administration in the para ventricular or amygdaloid nucleus on diet self selection. Brain Res Bull 1996; 39: 149-54
30. Corwin RL, Rowe PM, Crawley JN. Galanin and galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. Am J Physiol 1995; 269: R511-8
31. Koegler FH, Ritter S. Feeding induced by pharmacological blockade of fatty acid metabolism is selectively attenuated by hindbrain injections of the galanin receptor antagonist, M40. Obes Res 1996; 4: 329-36
32. Ritter S, Dinh TT. 2-Mercaptoacetate and 2-deoxy-D-glucose induce fos-like immunoreactivity in rat brain. Brain Res 1994; 641: 111-20
33. Leibowitz SF, Kim T. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res 1992; 599: 148-52
34. Crawley JN, Robinson JK, Langel U, et al. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res 1993; 600: 268-72
35. Bartfai T, Langel U, Bedecs K, et al. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci USA 1993; 90: 11287-91
36. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev 1987; 8: 256-87
37. Heinrichs SC, Menzaghi F, Pich EM, et al. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 1993; 611: 18-24
38. Menzaghi F, Heinrichs SC, Pich EM, et al. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Brain Res 1993; 618: 76-82
39. Behan DP, Heinrichs SC, Troncoso JC, et al. Urocortin, a mammalian neuropeptide related to fish urotensin and to corticotropin-releasing factor. Nature 1995; 378: 287-92
40. Spina M, Merlo-Pich E, Chan RK W, et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996; 273: 1561-4
41. Verbalis JG, Blackburn RE, Olson BR, et al. Central oxytocin inhibition of food and salt ingestion: a mechanism for intake regulation of solute homeostasis. Regul Pept 1993; 45: 149-54
42. Olson BR, Drutarosky MD, Stricker EM, et al. Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia. Am J Physiol 1991: 260: R448-52
43. Schwartz MW, Sipols AJ, Baskin DG, et al. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992; 13: 387-414
44. Sohda T, Mizuno K, Momose Y, et al. Studies on antidiabetogenic agents. 11: Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents. J Med Chem 1992; 35: 2617-26
45. Campfield LA, Smith FJ, MackieG, et al. Insulin normalization as an approach to the pharmacological treatment of obesity. Obes Res 1995; 3 Suppl. 4: 591S-603S
46. Morley JF, Flood JF. Amylin decreases food intake in mice. Peptides 1991; 12: 865-9
47. Lutz TA, Del Prete E, Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 1994; 55: 891-5
48. Lutz TE, Del Prete E, Szabady MM, et al. Attenuation of the anorectic effects of glucagon, cholecystokinin, and bombesin by the amylin receptor antagonist CGRP(8-37). Peptides 1996; 17: 119-24
49. Jin SLC, Han VKM, Simmons JG, et al. Distribution of glucagon-like peptide 1 (GLP-1), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 1988; 271: 519-32
50. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996; 379: 69-72
51. Tang-Christensen M, Larsen PJ, Goke R, et al. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 1996; 271: R848-56
52. Gibbs J, Smith GP, Satiety: the role of peptides from the stomach and the intestine. Fed Proc 1986; 45: 1391-5
53. Crawley JN, Corwin RL. Biological actions of cholecystokinin. Peptides 1994; 15: 731-55
54. Li BH, Rowland NE. Effects of vagotomy on cholecystokinin-and dexfenfluramine-induced fos-like immunoreactivity in the rat brain. Brain Res Bull 1995; 37: 589-93
55. Asin KE, Bednarz F, Nikkel AF, et al. Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide. Am J Physiol 1992; 263: R125-35
56. Hirosue Y, Inui A, Teranishi A, et al. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am J Physiol 1993; 265: R481-6
57. DeZube M, Sugg EE, Birkemo LS, et al. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands. J Med Chem 1995; 38: 3384-90
58. Muurahainen NE, Kissileff HR, Pi-Sunyer FX. Intravenous infusion of bombesin reduces food intake in humans. Am J Physiol 1993; 264: R350-4
59. Ladenheim EE, Ritter RC. Caudal hindbrain participation in the suppression of feeding by central and peripheral bombesin. Am J Physiol 1993; 264: R1229-34
60. 6]Bombesin(6-13)methyl ester, but not BW2258U89, increases food intake in rats. Pharmacol Biochem Behav 1995; 50: 463-71
61. Laferrere B, Leroy E, Bonhomme G, et al. Effects of bombesin, of a new bombesin agonist (BM187) and a new antagonist (BIM189) on food intake in rats, in relation to cholecystokinin. Eur J Pharmacol 1992; 215: 23-8
62. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32
63. Considine RV, Sriha M, Heilman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292-5
64. Schwartz MW, Peskind E, Raskind M, et al. Cerebrospinal fluid leptin level: relationship to plasma levels and adiposity in humans. Nature Med 1996; 2: 589-93
65. Halaas JL, Gajiwala KS, Maffei SL, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6
66. Pellymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-3
67. Campfield LA, Smith FJ, Guisez Y, et al. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-9
68. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-2
69. Smith FJ, Campfield LA, Moschera JA, et al. Feeding inhibition by neuropeptide Y. Nature 1996; 382: 307
70. Mercer JG, Hoggard N, Williams LM, et al. Localisation of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996; 387: 113-6
71. Mercer JG, Hoggard N, Williams LM, et al. Expression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996; 8: 733-5
72. Samson WK, Murphy TC, Robison D, et al. A 35 amino acid fragment of leptin inhibits feeding in the rat. Endocrinology 1996; 137: 5182-5
73. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992; 71: 1195-204
74. Lu D, Willard D, Patel IR, et al. Agouti protein is an antagonist of the melanocyte stimulating-hormone receptor. Nature 1994; 371: 799-802
75. Mountjoy KG, Mortrud MT, Low MJ, et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8: 1298-308
76. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-41
77. Fan W, Boston BA, Kesterson RA, et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-8